OpGen Inc. (Nasdaq: OPGN) is seeking regulatory approval of its QuickFish diagnostic test with a digital imager. The stock price more than doubled by leaping $2.13 to close at $3.70.
OpGen seeks approval
July 20, 2016 at 19:06 PM EDT
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.